The stock's fall snapped a two-day winning streak.

Communications-services companies fell sharply as traders retreated from high-risk areas. Cell-phone carriers, which long traded in lock-step, have diverged in recent years, with T-Mobile US far ...

AbCellera Biologics Inc. (NASDAQ: ABCL) is one of the 13 Stocks Under $5 With High Upside Potential. On May 16, Truist ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

Stem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...

What was supposed to be a five-year, $750,000 NIH grant to fund Dr. Charity Oyedeji's sickle cell research at Duke University ...

FutureDial builds on the success of its SMART Receive platform with SMART Receive Automation (SRA), the industry's fastest and most comprehensive mixed-load receiving cell, developed in partnership ...

Dow Inc. (DOW) ended the recent trading session at $27.15, demonstrating a +1.23% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0. ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

Some stem cell experts, including Dr. Knoepfler, are worried that the F.D.A. may loosen oversight on stem cell therapy, which could confuse the public about the difference between scientifically ...

The Dow fell more than 1,200 points Monday as Wall Street worried whether President Donald Trump’s attacks on the Federal Reserve chair were more than just bluster. The Dow was down 1,260 points ...